Pharmaceutical expenditure

Ebook "Health care spending in the new EU member states: Controlling costs and improving quality" are to take stock of recent trends in health expenditure aggregates in the public sector and to identify specific areas of reform consistent with the objectives of consolidating the fiscal situation in these countries without adversely affecting the production, delivery and utilization of health services.

72p tuongnhuoclan 28-11-2023 6 4   Download

Antibiotics administered incorrectly may result in detrimental consequences, such as prolonging treatment duration, causing adverse effects, or even increasing mortality. The research aimed to examine the characteristics of the antibiotics list utilized at PDHC in 2019.

7p viwarmachine 03-07-2023 3 2   Download

Therapeutic reference pricing (TRP) based on the WHO daily defined dose (DDD) is a method frequently employed for the cost-containment of pharmaceuticals. Our objective was to compare average drug use in the real world with DDD and to evaluate whether TRP based on DDD could result in cost savings on maintenance medication and the total direct health expenditures for asthma patients treated with Symbicort Turbuhaler (SYT) and Seretide Diskus (SED) in Hungary.

7p vianthony2711 16-04-2021 14 1   Download

The military health system, as well as the private health care sector, has experienced rapid growth in pharmaceutical expenditures. In 2002 alone, the Department of Defense spent about $3 billion on outpatient pharmacy benefits. As part of an effort to redesign the TRICARE pharmacy benefit to save costs, the Department

0p xuancoem 01-02-2013 33 4   Download

von der Schulenburg et al. Health Economics Review 2011, 1:18 http://www.healtheconomicsreview.com/content/1/1/18 RESEARCH Open Access The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors Fritz von der Schulenburg1,2, Sotiris Vandoros1 and Panos Kanavos1* Abstract This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices.

8p dauphong13 10-02-2012 57 4   Download